List your tool

Head to head · 2026

DrugCard vs Narrativa

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

DrugCard

AI-powered literature-screening platform that automates pharmacovigilance and adverse-event monitoring across languages

4.2Not listed

Visit DrugCard (opens DrugCard in a new tab)

Narrativa

Agentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready,…

3.6Not listed

Visit Narrativa (opens Narrativa in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: DrugCard does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    DrugCard

    4.2 against 3.6

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onDrugCardNarrativa
Our rating4.2Better3.6
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • AI literature screening across 100+ languages
  • Coverage of 1,500+ local and international medical journals
  • Adverse-event signal detection for pharmacovigilance teams
  • Regulatory intelligence and safety database tooling
  • Automated global assessment reporting
  • Agentic AI generates clinical study reports and patient narratives
  • Knowledge graph technology for complex clinical relationships
  • GxP-ready validation architecture
  • GDPR-aligned and HIPAA-ready data handling
  • Risk-based AI safety framework aligned with FDA/EMA guidance
Pros
  • Local-language coverage addresses a gap most competitors leave open
  • Founded by someone with direct pharmacovigilance industry experience
  • Operating in 121+ countries with a substantial processed-article volume
  • Purpose-built compliance architecture (GxP/FDA/EMA-aligned), not generic enterprise AI
  • Covers the full documentation chain from clinical data through regulatory submission
  • Knowledge graph approach suits the complex, interlinked nature of clinical data
Cons
  • No published pricing, so budgeting requires a sales conversation
  • Narrow focus on pharmacovigilance limits use outside drug safety
  • Small company relative to larger regulatory-software vendors
  • No published pricing - an enterprise sales process
  • Built specifically for regulated life sciences, not a general documentation tool
  • High-stakes regulatory output still requires expert human review before submission
CompanyDrugCards, founded 2019Narrativa

Prices come from each vendor's pricing page, last checked 20260826. Check the vendor before you buy.

FAQ

Questions people ask

Is DrugCard better than Narrativa?

In our reviews DrugCard scores 4.2 and Narrativa scores 3.6. The better pick depends on the job. DrugCard: AI-powered literature-screening platform that automates pharmacovigilance and adverse-event monitoring across languages. Narrativa: Agentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready, GDPR-aligned, and built to an FDA/EMA-aligned safety framework.

Which is cheaper, DrugCard or Narrativa?

DrugCard: see pricing. Narrativa: see pricing.

Do DrugCard and Narrativa have free plans?

Neither lists a free plan.

More comparisons